# US 2011/0217379 A1 · Magnetic nanomaterials and methods for chemoembolisation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0217379 A1
- Document ID: US20110217379A1
- Status: Published application
- Kind: A1
- Application number: 13/040,873
- Filed: 2011-03-04
- Published: 2011-09-08
- Earliest claimed: 2010-03-08
- Assignees: Davis LLP
- Inventors: Yixiang Wang; Ken Cham-Fai Leung; Chris Hon Ki Cheng; Ling Qin
- Web page: https://patentgrep.com/patent/US20110217379A1

## CPC

- A61K 9/50: Microcapsules {having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals (A61K9/2081 takes precedence; particles with a single coating comprising drug A61K9/167)}
- A61K 9/0009: {involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis}
- A61K 31/745: Polymers of hydrocarbons
- A61K 31/765: Polymers containing oxygen
- A61K 41/0028: {Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds}
- C08L 29/04: Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61L 2430/36: for embolization or occlusion, e.g. vaso-occlusive compositions or devices
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

There are disclosed magnetic nanoparticles and embolisation compositions comprising the nanoparticles. There are also disclosed methods to make the nanoparticles and embolisation compositions and methods to deliver therapeutic agents to a subject.

## Claims

### Claim 1

An embolization composition comprising:
a biodegradable matrix encapsulating at least one nanoparticle, wherein degradation of the matrix releases the nanoparticle.

### Claim 2 (depends on 1)

The embolisation composition according to claim 1 wherein the nanoparticle is hollow.

### Claim 3 (depends on 2)

The embolisation composition according to claim 2 wherein the nanoparticle is a superparamagnetic porous nanoparticle.

### Claim 4 (depends on 2)

The embolisation composition according to claim 2 wherein said nanoparticle contains a therapeutically effective amount of a therapeutic agent.

### Claim 5 (depends on 1)

The embolisation composition according to claim 1 wherein the matrix comprises PVA.

### Claim 6 (depends on 4)

The embolisation composition according to claim 4 wherein the therapeutic agent is an anticancer agent.

### Claim 7 (depends on 1)

The embolisation composition according to claim 1 wherein the nanoparticle is coated with:
a separating agent; or
a targeting agent; or
a separating agent and a targeting agent.

### Claim 8 (depends on 1)

A method of selectively obstructing blood flow in a blood vessel in a patient, the method comprising the steps of:
administering to the patient an embolization composition according to claim 1 for purposively inducing an embolism in said patient blood vessel.

### Claim 9 (depends on 1)

A method for delivering a therapeutic agent to a patient, the method comprising the steps of:
administering to the patient an embolisation composition according to claim 1 that contains the therapeutic agent; and
releasing the therapeutic agent.

### Claim 10 (depends on 9)

The method according to claim 9 wherein the method further comprises introducing said embolisation composition into a blood vessel supplying blood to a target region.

### Claim 11 (depends on 9)

The method according to claim 9 further comprising the step of applying a magnetic field to position said embolisation composition.

### Claim 12 (depends on 10)

The method according to claim 10 wherein said target region comprises a tumor.

### Claim 13

A method for making an embolisation composition, the method comprising the step of embedding at least one nanoparticle in a degradable matrix to thereby form the embolisation composition.

### Claim 14 (depends on 13)

The method according to claim 13 wherein said nanoparticle contains a therapeutic agent.

### Claim 15 (depends on 9)

The method according to claim 9 wherein said nanoparticle is a hollow, superparamagnetic nanoparticle.

### Claim 16 (depends on 14)

The method according to claim 14 wherein when said matrix suppresses the release of said therapeutic agent.

### Claim 17 (depends on 14)

The method according to claim 14 wherein the therapeutic agent is an anticancer agent.

### Claim 18 (depends on 13)

The method according to claim 13 wherein the nanoparticle is coated with:
a separating agent; or
a targeting agent; or
a separating agent and a targeting agent.

### Claim 19

A method for inhibiting growth of a cancer, the method comprising the step of inhibiting the blood supply to said cancer with a degradable embolisation composition
said embolisation composition comprising a degradable matrix, a plurality of magnetic nanoparticles, and a therapeutically effective amount of an anticancer agent.

### Claim 20 (depends on 19)

The method according to claim 19 wherein said nanoparticles are embedded in said matrix and carry said therapeutic agent, and wherein said method further comprises the steps of:
allowing ones of said nanoparticles to escape from the blood vessel carrying said blood supply; and
releasing the anticancer agent from said nanoparticles.
